Australia Biotech Invest 2014

Australia Biotech Invest 2014 is just three weeks away.

To attend Australia’s largest biotech showcase and spot your next biotech investment, apply for your complimentary investor pass online today or call Gwendoline Mascarenhas on +852 2531 6129.

Hear from over 30 expert speakers and panellists, 30 presenting biotech companies and meet with over 250 delegates from Australia's life science investor community at the Crown Conference Center on 3-4 December 2014. Don’t miss out, register today.

Here is a selection of who you will meet at Australia Biotech Invest 2014:

• A Menarin • Actinogen • Afandin • AFG Venture Group • Alphastation Communications • Amedus • Analytica • Antipodean Capital • AstraZeneca • ASX • AusIndustry

• BioAngels • BioDiem • Bionomics • BioPacific Partners • Bioscience Managers • Biotron • Blue Sky Venture Capital • BlueMount Capital • Borson Law Group

• Capital K Consulting • Cell Therapies • China Biocapital • China Renaissance Group • China Renaissance Partners • CIMB • Circadian • Clinical Genomics • Clinical Network Services • Contango Asset Management • CSIRO • CSL • Cygnet Capital • Cytomatrix

• Dewver • DorsaVi

• Edison Group • Elastagen

• Fairview Equity Partners • Farallon Capital Management • FB Rice • FitGenes • Fitzroy Capital • Forrest Capital • Fountain Medical Development • Freehills Patent Attorneys

• GBS Venture Partners • Global Data • Grannus Securities

• Hartleys • Hawkesbury Partners • Hirst Shabian & Hirst Advisory & Investment Services • Hydrix

• IDT Australia • Immuron • Imugene • Innate Immunotherapeutics • Innovation Capital • inVentiv Health Clinical • Invest HK • Invion • iQX

• Johnson Winter & Slattery Lawyers

• KPMG • LBT Innovations

• Lonza Biologics

• Macquarie Bank • MedImmune Ventures • Mercury CapitaI Investments • Morgans Financial

• Newcontent • Novo Nordisk Pharmaceuticals • NTD Patent & Trademark Agency

• Ondata Corporate Services • Oxford Capital

• Paphyl Investments • Paranta Biosciences • Patersons Securities • Patrys • Pfizer • Phylogica • Planet Innovation • Platinum Road • Polynoma • PricewaterhouseCoopers

• Quintiles

• Regeneus • Roche

• Scientia Capital • Sixty Degrees Pharmaceuticals • Somerset Capital • Starfish Ventures

• Talu Ventures • Terra Rossa Capital • Terrain Capital • Tewo Technology • The Hong Kong Polytechnic University • Thorney Investments Group • Trajan Scientific

• Uniseed Ventures • Universal Biosensors • University of Western Australia

• Venture Valuation • Virax

• Wilshire Private Markets • WuXi AppTec

• Zai Laboratory • Zhejiang Beta Pharma

Five key reasons to attend Australia Biotech Invest 2014:

1.Hear the pipeline of at least 30 Australian Biotech companies, as well as 5 international companies

2.Take part in fruitful discussions through the biopartnering system

3.Listen to expert panellists and keynote speakers discuss the trends and opportunities in biotech currently

4.Liaise and network with investors, pharma representatives, and biotech companies

5.Be a part of one of the most important events on the life sciences calendar

Download the full conference program here: http://www.theaustralianinvestor.com.au/linkt.aspx?id=658

To claim your investor pass click here: http://www.theaustralianinvestor.com.au/linkt.aspx?id=657 or call Gwendoline Mascarenhas on +852 2531 6129.

We look forward to meeting you at the conference in three weeks




I wonder why ANTISENSE THERAPEUTICS LIMITED
are not at the conference or have I missed something?

Would it benefit ANTISENSE THERAPEUTICS LIMITED to be at the conference?

Perhaps ANP are in the process of ???

Any comments shareholders?